Ironwood Pharmaceuticals, Inc. (IRWD)
3.49
-0.01
(-0.29%)
USD |
NASDAQ |
May 19, 09:42
Ironwood Pharmaceuticals Research and Development Expense (Quarterly) : 21.50M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| AbbVie, Inc. | 2.472B |
| Recursion Pharmaceuticals, Inc. | 75.20M |
| Cytokinetics, Inc. | 92.15M |
| Geron Corp. | 14.96M |
| Gilead Sciences, Inc. | 1.354B |